pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

5,159 catalysts · 5,159 phase readout · 2,286 8k filing · 315 pdufa · 256 earnings · 2 approval · 1 adcom

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-27: 0 catalysts2026-07-28: 0 catalysts2026-07-29: 0 catalysts2026-07-30: 14 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 13 catalysts2026-08-05: 16 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 1 catalyst2026-10-21: 0 catalysts2026-10-22: 2 catalysts2026-10-23: 0 catalysts2026-10-24: 0 catalysts2026-10-25: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: phase readout×clear all
type
  • phase readout5,159
  • 8k filing2,286
  • pdufa315
  • earnings256
  • approval2
  • adcom1
therapy area

no tagged catalysts yet

Date TBD

50
›NOT_YET_RECRUITINGphase readoutNCT07512115: The Impact of 'A Miss Is as Good as a Mile': Is Compensation Necessary for Minimal Ocular Deviation in Myopic Laser Surgery?

Sponsor: Zhongshan Ophthalmic Center, Sun Yat-sen University. Phase: NA. Conditions: Myopia, Refractive Ametropia

full page →ctgov ↗
›RECRUITINGphase readoutNCT07532915: A Multicenter, Prospective, Randomized Controlled Study on EUS-Guided Precise Disconnection of Varices Versus Endoscopic Gastric Variceal Glue Injection for the Prevention of Gastric Variceal Bleeding.

Sponsor: Nanfang Hospital, Southern Medical University. Phase: NA. Conditions: Gastric Variceal

full page →ctgov ↗
›COMPLETEDphase readoutNCT00893035: Evaluation of an Apoptotic Test for Predicting Late Toxicities After Radiotherapy in Breast and Prostate Cancer Patients

Sponsor: Institut du Cancer de Montpellier - Val d'Aurelle. Phase: . Conditions: Breast Cancer, Prostate Cancer

full page →ctgov ↗
›COMPLETEDphase readoutNCT07324408: Multiple Ascending Dose Study of NH102 in Healthy Subjects

Sponsor: Jiangsu Nhwa Pharmaceutical Co., Ltd.. Phase: PHASE1. Conditions: Depression

full page →ctgov ↗
›RECRUITINGphase readoutNCT06760208: A Study to Learn More About Prevenar 20 Once it is Out in the Korean Market

Sponsor: Pfizer. Phase: . Conditions: Pneumococcal Immunization, Safety

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07337408: Characterization of Weaning Practices in ICUs of Global South Countries

Sponsor: Hospital do Coracao. Phase: . Conditions: Weaning From Mechanical Ventilation, Weaning Failure, Weaning From Mechanical Ventilation, Extubation

full page →ctgov ↗
›RECRUITINGphase readoutNCT07542925: Prediction of Postoperative ICU Requirement in Oncologic Surgery

Sponsor: Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital. Phase: . Conditions: Neoplasms, Postoperative Complications, Perioperative/Postoperative Complications, Intensive Care Units

full page →ctgov ↗
›RECRUITINGphase readoutNCT07232576: A Phase 2 Study to Evaluate the Efficacy, Safety and Pharmacokinetics of SHR-1139 in Patients With Moderate-to-severe Active Ulcerative Colitis

Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd. Phase: PHASE2. Conditions: Adult Patients With Moderately to Severely Active Ulcerative Colitis

full page →ctgov ↗
›RECRUITINGphase readoutNCT06357676: Glofitamab Plus Ibrutinib With Obinutuzumab for the Treatment of Patients With Mantle Cell Lymphoma, IGNITE MCL Trial

Sponsor: OHSU Knight Cancer Institute. Phase: PHASE1. Conditions: Mantle Cell Lymphoma

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07038317: A Text Messaging Trial to Test Vaping Health Messages Optimized to Young Adults' Vaping Status

Sponsor: University of Hawaii. Phase: NA. Conditions: Vaping Behaviors, Message Exposure, Young Adults

full page →ctgov ↗
›COMPLETEDphase readoutNCT06614140: Personalized Neoantigen Cancer Vaccine for Patients With Solid Tumors

Sponsor: Seqker Biosciences, Inc.. Phase: PHASE1. Conditions: Cancer, Solid Tumor, Adult

full page →ctgov ↗
›COMPLETEDphase readoutNCT07323589: Impact of Myo-Inositol Alone vs Myo-Inositol Plus Metformin on Conception, Adherence, and Tolerability in PCOS

Sponsor: PAEC general hospital. Phase: PHASE3. Conditions: PCOS (Polycystic Ovary Syndrome)

full page →ctgov ↗
›RECRUITINGphase readoutNCT07202650: THE EFFECT OF GUİDED IMAGERY ON PREMENSTRUAL SYNDROME

Sponsor: Baskent University. Phase: NA. Conditions: Guided Imagery, Premenstrual Syndrome, Nursing

full page →ctgov ↗
›COMPLETEDphase readoutNCT01765374: Study of Sonographic Efficacy of Rituximab in Rheumatoid Arthritis

Sponsor: University Hospital, Rouen. Phase: PHASE4. Conditions: Rheumatoid Arthritis

full page →ctgov ↗
›RECRUITINGphase readoutNCT05436418: The Lowest Effective Dose of Post-Transplantation Cyclophosphamide in Combination With Sirolimus and Mycophenolate Mofetil as Graft-Versus-Host Disease Prophylaxis After Reduced Intensity Conditioning and Peripheral Blood Stem Cell Transplantation

Sponsor: National Cancer Institute (NCI). Phase: PHASE1. Conditions: Peripheral Blood Stem Cell Transplantation, Hematopoietic Stem Cell Transplantation

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT04626518: Substudy 03B: A Study of Immune and Targeted Combination Therapies in Participants With Second Line Plus (2L+) Renal Cell Carcinoma (MK-3475-03B/KEYMAKER-U03)

Sponsor: Merck Sharp & Dohme LLC. Phase: PHASE1. Conditions: Carcinoma, Renal Cell

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07074418: Effect of Empagliflozin in Patients With eGFR Between 10 and 20 ml/Min/1.73m2

Sponsor: Centre Hospitalier Universitaire de Nice. Phase: PHASE4. Conditions: Chronic Kidney Diseases

full page →ctgov ↗
›RECRUITINGphase readoutNCT06121297: RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus

Sponsor: Cabaletta Bio. Phase: PHASE1. Conditions: Systemic Lupus Erythematosus, Lupus Nephritis

full page →ctgov ↗
›COMPLETEDphase readoutNCT07314710: Factors Affecting Postural Awareness in Academics

Sponsor: Kutahya Health Sciences University. Phase: . Conditions: Health Adult Subjects

full page →ctgov ↗
›COMPLETEDphase readoutNCT07478913: Predictive Value of Endobronchial Sonographic Patterns in Diagnosis of Mediastinal Lymphadenopathy

Sponsor: Ain Shams University. Phase: . Conditions: Endobronchial Sonographic Patterns

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07427420: Postoperative Pain After Pulpectomy in Primary Molars

Sponsor: Cairo University. Phase: NA. Conditions: Irreversible Pulpitis

full page →ctgov ↗
›TERMINATEDphase readoutNCT06487858: A Study of BGB-R046 as Monotherapy and in Combination With Tislelizumab in Solid Tumors

Sponsor: BeOne Medicines. Phase: PHASE1. Conditions: Solid Tumor

full page →ctgov ↗
›RECRUITINGphase readoutNCT07343258: Pilot Study on Follow-Up of (Acutely) Suicidal Individuals From the Flemish Suicide Helpline

Sponsor: University Ghent. Phase: NA. Conditions: Suicide, Suicidal Ideation and Behavior, Crisis Intervention

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06652958: A Study to Assess the Safety and Pharmacokinetics of a Human Monoclonal Antibody (VH4527079) in Healthy Adults and Persons With HIV

Sponsor: ViiV Healthcare. Phase: PHASE1. Conditions: HIV Infections

full page →ctgov ↗
›RECRUITINGphase readoutNCT04450758: Acute Colon Resection Versus Bridge to Colon Surgery With Stent or Stoma

Sponsor: Skane University Hospital. Phase: . Conditions: Colon Cancer

full page →ctgov ↗
›COMPLETEDphase readoutNCT03726658: Zelquistinel in the Treatment of Adults With Major Depressive Disorder

Sponsor: Syndeio Biosciences, Inc. Phase: PHASE1. Conditions: Major Depressive Disorder

full page →ctgov ↗
›RECRUITINGphase readoutNCT05272826: Study of Iberdomide, Bortezomib, Dexamethasone With Isatuximab Added on Demand for ND-NTE MM Patients

Sponsor: Canadian Myeloma Research Group. Phase: PHASE2. Conditions: Multiple Myeloma

full page →ctgov ↗
›COMPLETEDphase readoutNCT05934526: Efficacy and Safety of Seralutinib in Adult Subjects With PAH (PROSERA)

Sponsor: GB002, Inc.. Phase: PHASE3. Conditions: Pulmonary Arterial Hypertension

full page →ctgov ↗
›RECRUITINGphase readoutNCT07101926: Monitoring of Anti-TFPI in Hemophilia

Sponsor: Hospices Civils de Lyon. Phase: . Conditions: Hemophilia, Rebalancing Agents, Prophylaxis

full page →ctgov ↗
›COMPLETEDphase readoutNCT03283878: Antibiotic Prophylaxis in Patients Undergoing Elective Total Knee Arthroplasty- Multi-center Trial

Sponsor: Duke University. Phase: PHASE4. Conditions: Arthropathy of Knee, Antibiotic Prophylaxis

full page →ctgov ↗
›RECRUITINGphase readoutNCT04227678: Postprandial Fatty Acid Metabolism in Subjects With Lipoprotein Lipase Deficiency

Sponsor: Université de Sherbrooke. Phase: NA. Conditions: Lipoprotein Lipase Deficiency

full page →ctgov ↗
›TERMINATEDphase readoutNCT00426985: Efficacy and Safety of Ketoprofen Topical Patch 20% in the Treatment of Pain Associated With Shoulder, Elbow or Knee Tendonitis or Bursitis

Sponsor: APR Applied Pharma Research s.a.. Phase: PHASE3. Conditions: Tendonitis, Bursitis

full page →ctgov ↗
›COMPLETEDphase readoutNCT03832985: Pediatric Reporting of Adult-Onset Genomic Results

Sponsor: Geisinger Clinic. Phase: EARLY_PHASE1. Conditions: Hereditary Breast and Ovarian Cancer Syndrome, Lynch Syndrome, Familial Hypercholesterolemia

full page →ctgov ↗
›TERMINATEDphase readoutNCT04058743: Nickel Sensitivity

Sponsor: Rush University Medical Center. Phase: NA. Conditions: Knee Arthropathy, Allergic Reaction

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06457555: Knowledge Levels and Experiences of Intensive Care Nurses on the Prevention of Pressure Sores: Mixed Method

Sponsor: Burdur Mehmet Akif Ersoy University. Phase: . Conditions: Nurses, Pressure Ulcer, Critical Care

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07451925: Prediction of Postoperative Pain Using Venous Cannulation Pain and Preoperative Anxiety Scores

Sponsor: Fatih Sultan Mehmet Training and Research Hospital. Phase: . Conditions: Preoperative Anxiety, Postoperative Pain

full page →ctgov ↗
›COMPLETEDphase readoutNCT03965325: FOcUs on Colorectal CAncer oUtcomes: Long-Term Study

Sponsor: IHU Strasbourg. Phase: . Conditions: Colorectal Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT05066217: An Efficacy and Safety Study of Clemizole HCl in Patients With Lennox-Gastaut Syndrome

Sponsor: Epygenix. Phase: PHASE3. Conditions: Lennox Gastaut Syndrome

full page →ctgov ↗
›RECRUITINGphase readoutNCT06157840: Development of an mHealth Behavioral Sleep Medicine Intervention for Use During Medication Assisted Treatment for MOUD

Sponsor: Medical University of South Carolina. Phase: NA. Conditions: Opioid Use Disorder, Poor Quality Sleep

full page →ctgov ↗
›RECRUITINGphase readoutNCT07487740: A Food Effect Study to Evaluate the Relative Bioavailability of Nalbuphine Extended-Release Tablets (NAL ER) in Healthy Participants

Sponsor: Trevi Therapeutics. Phase: PHASE1. Conditions: Healthy Participants

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT04821089: A Study to Assess the Safety and Efficacy of IPN10200 in Adult Participants With Moderate to Severe Upper Facial Lines

Sponsor: Ipsen. Phase: PHASE1. Conditions: Moderate to Severe Upper Facial Lines

full page →ctgov ↗
›COMPLETEDphase readoutNCT02362750: Evaluating Cancer Survivorship Care Models

Sponsor: George Washington University. Phase: . Conditions: Quality of Life, Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT06276491: Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors

Sponsor: Xencor, Inc.. Phase: PHASE1. Conditions: Ovarian Cancer, Endometrial Cancer, Germ Cell Tumor, Testicular Germ Cell Tumor, Ovarian Germ Cell Tumor

full page →ctgov ↗
›COMPLETEDphase readoutNCT07236918: The Concert Therapy Pilot Study for Stress Reduction and Wellbeing

Sponsor: BeHnam KhodaRahmi. Phase: NA. Conditions: Stress Reduction, Psychological Wellbeing, Mental Health, Music Therapy

full page →ctgov ↗
›COMPLETEDphase readoutNCT03478839: Study of People With Generalized Arterial Calcification of Infancy (GACI) or Autosomal Recessive Hypophosphatemic Rickets Type 2 (ARHR2)

Sponsor: National Human Genome Research Institute (NHGRI). Phase: . Conditions: Generalized Arterial Calcification of Infancy, Autosomal Recessive Hypophosphatemic Rickets Type2

full page →ctgov ↗
›RECRUITINGphase readoutNCT07517575: Pharmacokinetics, Efficacy and Safety of Olokizumab In Patients With Juvenile Idiopathic Arthritis

Sponsor: R-Pharm International, LLC. Phase: PHASE2. Conditions: Juvenile Idiopathic Arthritis

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07528001: Hypno-Breastfeeding Education and Postpartum Outcomes

Sponsor: Saglik Bilimleri Universitesi. Phase: NA. Conditions: Postpartum Anxiety

full page →ctgov ↗
›RECRUITINGphase readoutNCT06272812: A Study to Evaluate the Efficacy, Safety and Immunogenicity of MTBVAC in Adolescents and Adults Living in a TB Endemic Region.

Sponsor: International AIDS Vaccine Initiative. Phase: PHASE2. Conditions: Tuberculosis (TB)

full page →ctgov ↗
›RECRUITINGphase readoutNCT07215312: A Study of LY3938577 in Participants With Type 2 Diabetes Previously Treated With Basal Insulin

Sponsor: Eli Lilly and Company. Phase: PHASE2. Conditions: Diabetes Mellitus, Type 2

full page →ctgov ↗
›RECRUITINGphase readoutNCT07290881: Comparing the Postoperative Analgesic Efficacy of Anterior Iliac Block and Ilioinguinal-iliohypogastric Block in Inguinal Hernia Surgery

Sponsor: Harran University. Phase: NA. Conditions: Acute Pain

full page →ctgov ↗
← prev
page 18 of 104
next →